Journals / Türk Osteoporoz Dergisi / 2017 / Cilt: 23 - Sayı: 1

From Complication to Diagnosis: Prostate Cancer in an Acetabular Fracture Patient Presenting with Hip Pain

Komplikasyondan Tanıya: Kalça Ağrısı ile Başvuran Asetabular Kırıklı Olguda Prostat Kanseri

Pages
26–28
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Significant pain palliation was achieved in the patient who is diagnosed with primer prostate carcinoma after radiation therapy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:According to the Turkish Public Health Institution data, prostate cancer is the 2nd most common cancer in men.
📊
Key Findings & Data:In this case report, a 66 year-old man who has hip pain referred to our rheumatology department with sacroiliitis is presented.
💡
Conclusion & Impact:Significant pain palliation was achieved in the patient who is diagnosed with primer prostate carcinoma after radiation therapy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

According to the Turkish Public Health Institution data, prostate cancer is the 2nd most common cancer in men. Advanced stage patients may apply with pain in the lower back, hips, or upper thighs. In this case report, a 66 year-old man who has hip pain referred to our rheumatology department with sacroiliitis is presented. Further investigations revealed that hip pain was the result of acetabular fracture due to osteoblastic bone metastases. Significant pain palliation was achieved in the patient who is diagnosed with primer prostate carcinoma after radiation therapy

Özet

Türk Halk Sağlığı Kurumu verilerine göre prostat kanseri, ülkemizde erkeklerde en sık görülen 2. kanser türüdür. İleri evrede olgular karşımıza bel, kalça, uyluk ağrısı gibi şikayetlerle başvurabilirler. Bu olgu sunumunda, 66 yaşında kalça ağrısı olan ve romatoloji polikliniğimize sakroileit nedeni ile refere edilmiş bir olgu sunulmuştur. Olgunun ileri tetkiklerinde kalça ağrısının, osteoblastik kemik metastazı sonucu gelişen asetabular kırığa bağlı olduğu anlaşılmıştır. Primer prostat kanseri tanısı konan olguda radyoterapi sonrasında belirgin ağrı palyasyonu sağlanmıştır

🔖

Cite This Article

KURAN, K. B., YILMAZ, F., TERLEMEZ, R. (2022). From Complication to Diagnosis: Prostate Cancer in an Acetabular Fracture Patient Presenting with Hip Pain. Türk Osteoporoz Dergisi, Cilt: 23 - Sayı: 1, 26–28. https://ajindex.com/articles/639724

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Gültekin G, Güledal B. “Türkiye kanser istatistikleri.” Sağlık Bakanlığı, Türkiye Halk Sağlığı Kurumu 2014:43
  2. Suva LJ, Washam C, Nicholas RW, Griffin RJ. Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol 2011;7:208-18
  3. Sim FH. Metastatic bone disease of the pelvis and femur. Instr Course Lect 1992;41:317-27
  4. Singh PC, Patel DV, Chang VT. Metastatic acetabular fractures: Evaluation and approach to management. J Pain Symptom Manage 2006;32:502-7
  5. Clarke NW, McClure J, George NJ. Morphometric evidence for bone resorption and replacement in prostate cancer. Br J Urol 1991;68:74-80
  6. Issack PS, Kotwal SY, Lane JM. Management of metastatic bone disease of the acetabulum. J Am Acad Orthop Surg 2013;21:685- 95
  7. Hage WD, Aboulafia AJ, Aboulafia DM. Aboulafia. Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin North Am 2000;31:515-28
  8. Hoskin PJ. Radiotherapy for bone pain. Pain 1995;63:137-9
  9. Hillegonds DJ, Franklin S, Shelton DK, Vijayakumar S, Vijayakumar V. The management of painful bone metastases with an emphasis on radionuclide therapy. J Natl Med Assoc 2007;99:785-94
  10. Aapro M, Saad F, Costa L. Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases. Oncologist 2010;15:1147-58
  11. Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, et al. Zoledronic Acid Prostate Cancer Study Group. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormonerefractory prostate cancer. J Natl Cancer Inst 2004;96:879-82
  12. Fizazi K, Carducci M, Smith M, Damiao R, Brown J, Karsh L, et al. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 2011;377:813-22
  13. Saylor PJ. Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancer. Asian J Androl 2014;16:341-7
  14. Healey JH, Brown HK. Complications of bone metastases: surgical management. Cancer 2000;88(12 Suppl):2940-51